Table 3.
Prevalence of individual metabolic abnormalities among selected Chinese adults in Pudong New Area of Shanghai, China
| Metabolic abnormalities | Male (2477) | Female (3107) | Total (5583) | |||
|---|---|---|---|---|---|---|
| Number | % | Number | % | Number | % | |
| By WHO criteria | ||||||
| Impaired FPG or diabetes | 903 | 36.7 | 992 | 32.2 | 1895 | 34.2 |
| Central obesity | 973 | 39.3 | 1224 | 39.4 | 2197 | 39.3 |
| Elevated BP or hypertension | 778 | 31.4 | 927 | 29.8 | 1705 | 30.5 |
| Microalbuminuria | 19 | 0.8 | 51 | 1.6 | 70 | 1.3 |
| Hyperlipidemia | 1409 | 56.9 | 1485 | 47.8 | 2894 | 51.8 |
| No. of metabolic abnormalities | ||||||
| 0 | 483 | 19.6 | 859 | 27.9 | 1342 | 24.2 |
| 1 | 682 | 27.7 | 791 | 25.7 | 1473 | 26.6 |
| 2 | 675 | 27.4 | 696 | 22.6 | 1371 | 24.8 |
| 3 | 455 | 18.5 | 495 | 16.1 | 950 | 18.2 |
| 4 | 161 | 6.5 | 226 | 7.3 | 387 | 7.0 |
| 5 | 4 | 0.2 | 13 | 0.4 | 17 | 0.3 |
| By modified ATP III or IDF criteria | ||||||
| Increased WC | 548 | 22.1 | 1196 | 38.5 | 1744 | 31.2 |
| Elevated BP or hypertension | 1213 | 49.0 | 1393 | 44.8 | 2606 | 46.7 |
| Reduced HDL-C or use drug | 272 | 11.1 | 795 | 25.8 | 1067 | 19.3 |
| Elevated TG or use drug | 1455 | 59.2 | 1532 | 49.7 | 2987 | 54.0 |
| Impaired FPG or diabetes | 903 | 36.7 | 992 | 32.2 | 1895 | 34.2 |
| No. of metabolic abnormalities | ||||||
| 0 | 418 | 17.0 | 667 | 21.7 | 1085 | 19.6 |
| 1 | 663 | 27.0 | 677 | 22.0 | 1340 | 24.2 |
| 2 | 676 | 27.6 | 652 | 21.2 | 1328 | 24.0 |
| 3 | 460 | 18.8 | 557 | 18.1 | 1017 | 18.4 |
| 4 | 206 | 8.4 | 385 | 12.5 | 591 | 10.7 |
| 5 | 30 | 1.2 | 136 | 4.4 | 168 | 3.0 |